NorthWest Biotherapeutics Inc (NWBO)

[QL300]

I think we get close to $1.50 before the end of the month. Submittal should get us close to the $3 range.

I’m hoping the deal doesn’t involve equity. Even a relatively small deal with $100-$200 million prepayment should do wonders for the stock. It takes away the perceived Bankruptcy risk, dilution worries and the rest of the ridiculous bear arguments. A PR coming from someone like Merck will be seen by much more investors than any PR sent out by NWBO. Could trigger a short squeeze.